Clinical Trial Update: A Study to Understand the Treatment Patterns in Patients With Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension During a Switch of Treatment to Adempas in Real-life Clinical Practice

View source ↗

Summary

This completed study evaluated real-world treatment patterns in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Thromboembolic Pulmonary Hypertension

Drugs mentioned

• Adempas (riociguat)

Snippet

Sponsor: Bayer | Conditions: Hypertension, Pulmonary | Status: COMPLETED